INTRODUCTION
============

The immune system plays a crucial role in maintaining body health, not only by protecting the host against pathogenic agents including bacteria, fungi and virus but also by eliminating aged, mutant or dead cells in the body \[[@r1]--[@r3]\]. The abnormal immune function can cause many hazards, such as infectious disease, cancer, and autoimmune disease. Nevertheless, the most critical issue is the lack of laboratory tests that can quantitatively detect immune status. Currently, the clinicians commonly judge the immune status of hosts according to whether patients have underlying diseases such as diabetes mellitus, malignancy and chronic renal failure, and this is obviously inaccurate. Thus, the development of rapid and accurate methods for the detection and quantification of host immunity is of increasing importance in clinical practice.

Lymphocytes, which mainly consist of T cells, B cells and NK cells, are the key effector cells of immune system. Meanwhile, lymphocytes regulate immune system via activation, cytotoxicity, and secretion of cytokines. There are many methods reported to detect lymphocyte function in scientific research. \[^3^H\]-thymidine incorporation and carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeling assay are used to determine the proliferation of lymphocytes \[[@r4]--[@r6]\]. The activation markers including CD25, CD69 and HLA-DR are measured to reflect the activation of T cells and NK cells \[[@r7], [@r8]\]. Chromium (^51^Cr)-release assay has the ability to detect the cytotoxicity of CD8^+^ T cells and NK cells \[[@r9]\]. We also used CFSE/PI-labeled target cells to determine the cytotoxicity of NK cells \[[@r9], [@r10]\]. However, although these methods are widely used in previous studies, most of them are not suitable for clinical application due to radiation hazards, too complicated and time-consuming administration. The activation markers are easily detected in clinical laboratory, but they cannot represent lymphocyte function comprehensively.

Our previous study has shown that interferon-gamma (IFN-γ) production of CD4^+^ and CD8^+^ T cells and NK cells after 4 hours of phorbol-12-myristate-13-acetate/Ionomycin (PMA/Ionomycin) stimulation was positively correlated with the activation, chemotaxis, and cytotoxicity of them, which suggests that IFN-γ producing capability can be used as a marker of lymphocyte function \[[@r11]\]. This method is simple, rapid, and safe and has great value in clinical application. Recently, although many studies have focused on the change of lymphocyte number, function and phenotype in healthy individuals with different age groups or in patients with different diseases, few have investigated these aspects simultaneously \[[@r11]--[@r13]\]. For one thing, neither the number nor the phenotype can represent the function of lymphocytes, and for another, individuals with enhanced lymphocyte function may be in immunosuppressive state due to reduced lymphocyte number. Thus, understanding the host\'s immune status depends on comprehensive analysis of the number, function, and phenotype of lymphocytes.

In this study, based on our previous established PMA/ionomycin-stimulated lymphocyte function assay, we investigated the number, function, and phenotype of CD4^+^ T cells, CD8^+^ T cells and NK cells simultaneously in healthy individuals in different age and gender groups. We found that the number, function and phenotype of lymphocytes showed significant correlation with each other. We first established an immune scoring model based on combination of lymphocyte number, function and phenotype, and this model showed potential value in determining hyper-immune or hypo-immune status.

RESULTS
=======

Participants' characteristics
-----------------------------

A total of 261 healthy individuals fulfilled the inclusion criteria were recruited for the study, including 168 (64.4%) males and 93 (35.6%) females. The median age of the healthy individuals was 34 years (range: 1-82 years). The healthy individuals were divided into four groups according to their age range: 47 (18.01%) individuals (35 males, 12 females) aged 1-5 years were classified as children; 72 (27.59%) individuals (52 males, 20 females) aged 6-18 years were classified as adolescents; 90 (34.48%) individuals (53 males, 37 females) aged 18-65 years were classified as adults; 52 (19.92%) individuals (28 males, 24 females) aged \>65 years were classified as elders.

The reference ranges of lymphocyte number, function and phenotype in different age and gender groups
----------------------------------------------------------------------------------------------------

The analysis templates of flow cytometry for lymphocyte number, function and phenotype are shown in [Figure 1A](#f1){ref-type="fig"}--[1C](#f1){ref-type="fig"}, respectively. Given that all parameters in lymphocyte number, function and phenotype were correlated with age, the reference ranges of these parameters were established in four age groups (children, adolescents, adults, and elder). Four parameters were used to represent lymphocyte number: CD4^+^ T cell number, CD8^+^ T cell number, B cell number, and NK cell number. Three parameters were used to represent lymphocyte function: CD4^+^ T cell function (IFN-γ^+^CD4^+^ T cells %), CD8^+^ T cell function (IFN-γ^+^CD8^+^ T cells %), and NK cell function (IFN-γ^+^ NK cells %). Five parameters were used to represent lymphocyte phenotype: CD28^+^CD4^+^ T cells %, HLA-DR^+^CD4^+^ T cells %, CD45RO^+^CD4^+^ T cells %, CD28^+^CD8^+^ T cells %, and HLA-DR^+^CD8^+^ T cells %. The reference ranges of these parameters in healthy individuals in different age groups are shown in [Table 1](#t1){ref-type="table"}. The original TBNK percentage results are shown in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}. Moreover, most parameters in lymphocyte number, function, and phenotype had no significant difference between different gender groups. The reference ranges of these parameters in different gender groups are shown in [Supplementary Table 2](#SD2){ref-type="supplementary-material"}.

![**The analysis templates of flow cytometry** for lymphocyte number (**A**), function (**B**), and phenotype (**C**).](aging-12-103208-g001){#f1}

###### Reference ranges of lymphocyte number, function, and phenotype in different age groups.

  ----------------------------- ---------------------- --------------------------- --------------------------- --------------------------- --------------------------- --------------------------- ---------
  **Parameters**                                       **All**                     **Children**                **Adolescents**             **Adults**                  **Elders**                  **p**
  **N=261**                     **N=47**               **N=72**                    **N=90**                    **N=52**                                                                            
  Age                           Mean±SD (Range)        33.68±26.63 (1-82)          3.81±1.04 (1-5)             10.81±3.74 (6-18)           46±13.79 (18-65)            71.04±4.39 (66-82)          
  Sex                           Male:Female            168:93                      35:12                       52:20                       53:37                       28:24                       
  **Number**                                                                                                                                                                                       
  CD4^+^ T cell number (/ml)    Mean±SD (2.5%-97.5%)   836±355 (374-1881)          1260±399 (635-1979)         927±287 (560-1653)          648±203 (360-1074)          652±187 (367-1007)          \<0.001
  CD8^+^T cell number (/ml)     Mean±SD (2.5%-97.5%)   576±310 (154-1459)          880±343 (426-1553)          728±262 (397-1382)          424±171 (180-847)           355±154 (116-681)           \<0.001
  B cell number (/ml)           Mean±SD (2.5%-97.5%)   358±252 (73-1006)           695±251 (251-1240)          457±173 (218-905)           184±81 (53-352)             216±140 (67-537)            \<0.001
  NK cell number (/ml)          Mean±SD (2.5%-97.5%)   383±219 (103-920)           381±243 (89-905)            345±228 (86-934)            364±165 (154-732)           473±239 (125-1000)          \<0.05
  **Function**                                                                                                                                                                                     
  IFN-g^+^CD4^+^ T cells (%)    Mean±SD (2.5%-97.5%)   17.84±8.85 (6.62-36.81)     10.23±4.16 (4.08-17.17)     12.28±4.86 (5.43-20.35)     23.72±8.12 (12.34-40.53)    22.26±7.52 (8.83-34.43)     \<0.001
  IFN-g^+^CD8^+^ T cells (%)    Mean±SD (2.5%-97.5%)   46.25±22.43 (13.59-87.72)   26.89±10.77 (8.95-46.18)    29.13±10.83 (13.63-56.57)   56.08±17.92 (22.76-87.38)   70.46±14.33 (42.84-92.36)   \<0.001
  IFN-g^+^ NK cells (%)         Mean±SD (2.5%-97.5%)   72.68±12.65 (43.88-90.94)   67.28±14.57 (40.76-85.99)   67.77±13.16 (39.70-87.66)   77.29±9.95 (57.73-91.48)    76.37±9.52 (59.79-90.61)    \<0.001
  **Phenotype**                                                                                                                                                                                    
  CD28^+^CD4^+^ T cells (%)     Mean±SD (2.5%-97.5%)   94.95±7.03 (73.33-99.97)    98.17±4.03 (89.50-99.98)    97.92±2.72 (88.95-99.95)    92.81±7.6 (71.81-99.88)     91.61±9.10 (66.26-99.83)    \<0.001
  HLA-DR^+^CD4^+^ T cells (%)   Mean±SD (2.5%-97.5%)   14.33±7.45 (5.42-32.78)     9.68±4.79 (5.29-24.40)      10.64±4.15 (5.11-19.71)     16.23±7.02 (5.97-34.34)     20.35±8.25 (9.07-40.22)     \<0.001
  CD45RO+CD4^+^T cells (%)      Mean±SD(2.5%-97.5%)    50.89±18.88 (20.58-88.47)   28.77±7.71 (13.63-43.39)    40.37±9.88 (22.48-58.08)    61.09±14 (36.21-88.06)      67.82±14.07 (37.46-93.85)   \<0.001
  CD28^+^CD8^+^ T cells (%)     Mean±SD (2.5%-97.5%)   62.06±17.3 (26.41-88.91)    71.58±12.49 (52.47-91.71)   71.39±12.36 (45.28-88.65)   58±15.87 (26.72-84.13)      47.57±16.5 (20.60-82.40)    \<0.001
  HLA-DR^+^CD8^+^ T cells (%)   Mean±SD (2.5%-97.5%)   34.93±17.12 (9.97-71.53)    23.26±11.82 (7.42-47.14)    25.13±10.45 (9.98-46.31)    39.09±15.71 (14.96-72.95)   51.83±13.98 (22.97-74.98)   \<0.001
  ----------------------------- ---------------------- --------------------------- --------------------------- --------------------------- --------------------------- --------------------------- ---------

SD: standard deviation. *P* means association between different parameters and age in all participants by using Spearman\'s rank correlation test.

Some parameters which can reflect the combination effect between lymphocyte number and function or between lymphocyte number and phenotype (CD4^+^ T cell number × function, CD4^+^ T cell number × CD28^+^CD4^+^ T cells %, CD4^+^ T cell number × HLA-DR^+^CD4^+^ T cells %, CD4^+^ T cell number × CD45RO^+^CD4^+^ T cells %, CD8^+^ T cell number × function, CD8^+^ T cell number × CD28^+^CD8^+^ T cells %, CD8^+^ T cell number × HLA-DR^+^CD8^+^ T cells %, NK cell number × function) were further calculated, and the reference ranges of these calculated parameters are shown in [Table 2](#t2){ref-type="table"}.

###### Reference ranges of calculated parameters in different age groups.

  -------------------------------------------------------- ---------------------- -------------------- --------------------- -------------------- -------------------- -------------------- ---------
  **Parameters**                                                                  **All**              **Children**          **Adolescents**      **Adults**           **Elders**           **p**
  **N=261**                                                **N=47**               **N=72**             **N=90**              **N=52**                                                       
  Age                                                      Mean±SD (Range)        33.68±26.63 (1-82)   3.81±1.04 (1-5)       10.81±3.74 (6-18)    46±13.79 (18-65)     71.04±4.39 (66-82)   
  CD4^+^ T cell number × function (/ml)                    Mean±SD (2.5%-97.5%)   134±66 (56-293)      125±58 (57-225)       108±40 (57-209)      153±75 (61-328)      147±73 (44-311)      \<0.001
  CD8^+^ T cell number × function (/ml)                    Mean±SD (2.5%-97.5%)   237±139 (72-567)     240±143 (65-565)      212±126 (86-489)     242±143 (79-564)     259±74 (67-553)      \<0.05
  NK cell number × function (/ml)                          Mean±SD (2.5%-97.5%)   283±175 (49-736)     254±157 (37-585)      241±184 (44-780)     286±142 (90-674)     216±125 (80-832)     \<0.001
  CD4^+^ T cell number × CD28^+^CD4^+^ T cells % (/ml)     Mean±SD (2.5%-97.5%)   798±359 (333-1844)   1236±392 (631-1925)   909±288 (536-1638)   600±190 (318-1001)   594±173 (320-894)    \<0.001
  CD4^+^ T cell number × HLA-DR^+^CD4^+^ T cells % (/ml)   Mean±SD (2.5%-97.5%)   110±60 (36-257)      121±70 (43-299)       95±37 (44-176)       103±52 (35-232)      135±78 (47-339)      \<0.01
  CD4^+^ T cell number × CD45RO^+^CD4^+^ T cells % (/ml)   Mean±SD (2.5%-97.5%)   385±140 (192-709)    347±109 (220-557)     358±94 (225-570)     393±153 (165-735)    444±168 (219-748)    \<0.001
  CD8^+^ T cell number × CD28^+^CD8^+^ T cells % (/ml)     Mean±SD (2.5%-97.5%)   364±232 (82-949)     618±233 (243-1011)    508±174 (262-950)    236±98 (104-435)     134±50 (57-286)      \<0.001
  CD8^+^ T cell number × HLA-DR^+^CD8^+^ T cells % (/ml)   Mean±SD (2.5%-97.5%)   187±129 (41-547)     221±183 (38-565)      185±113 (67-452)     169±110 (39-478)     132±48 (46-436)      \>0.05
  -------------------------------------------------------- ---------------------- -------------------- --------------------- -------------------- -------------------- -------------------- ---------

SD: standard deviation. *P* means association between different parameters and age in all participants by using Spearman\'s rank correlation test.

Correlation analysis between different lymphocyte parameters and age
--------------------------------------------------------------------

For lymphocyte number, the absolute numbers of total T cells, CD4^+^ T cells, CD8^+^ T cells and B cells were all negatively correlated with age. In contrast, both the percentage and absolute number of NK cells were positively correlated with age ([Figure 2A](#f2){ref-type="fig"}). For lymphocyte function, the function of CD4^+^ and CD8^+^ T cells was low after birth, but increased with increasing age. Therefore, the function of both CD4^+^ and CD8^+^ T cells was positively correlated with age. The function of NK cells was also positively correlated with age. Differently, the function of NK cells was maintained at a high level after birth, and then slowly increased with increasing age ([Figure 2B](#f2){ref-type="fig"}). For lymphocyte phenotype, the expression of naive marker CD28 on both CD4^+^ and CD8^+^ T cells was negatively correlated with age. In contrast, the expression of activated marker HLA-DR on them was positively correlated with age. The expression of memory marker CD45RO on CD4^+^ T cells was also positively correlated with age ([Figure 2C](#f2){ref-type="fig"}).

![**Correlation analysis between different lymphocyte parameters and age.** (**A**) Heparinized peripheral blood was collected from study participants. The percentages and absolute numbers of CD4^+^ T cells, CD8^+^ T cells, B cells and NK cells were determined by flow cytometry. Correlation between lymphocyte count (including percentage and absolute number) and age. (**B**) PMA/ionomycin-stimulated lymphocyte function assay was performed in study participants. Correlation between lymphocyte function (including CD4^+^ T cells, CD8^+^ T cells, and NK cells) and age. (**C**) The expression of phenotype markers CD28, HLA-DR, and CD45RO on CD4^+^ and CD8^+^ T cells was analyzed by flow cytometry. Correlation between these phenotype markers and age. Each symbol represents an individual donor.](aging-12-103208-g002){#f2}

Correlation analysis among lymphocyte number, function and phenotype
--------------------------------------------------------------------

The numbers of CD4^+^ and CD8^+^ T cells were negatively correlated with the function of them. In contrast, NK cell number was slightly positively correlated with its function ([Figure 3A](#f3){ref-type="fig"}). The expression of CD28 on CD4^+^ T cells was positively correlated with the number of CD4^+^ T cells. Contrastingly, the expression of both HLA-DR and CD45RO on CD4^+^ T cells was negatively correlated with CD4^+^ T cell number. HLA-DR expression on CD8^+^ T cells was also negatively correlated with their number ([Figure 3B](#f3){ref-type="fig"}). Furthermore, CD28 expression on CD4^+^ and CD8^+^ T cells was negatively correlated with HLA-DR expression on them. CD28 expression on CD4^+^ T cells was also negatively correlated with their CD45RO expression. On the other hand, CD28 expression on both CD4^+^ and CD8^+^ T cells was negatively correlated with their function. On the contrary, HLA-DR and CD45RO expression on CD4^+^ and CD8^+^ T cells was positively correlated with their function ([Figure 3C](#f3){ref-type="fig"}).

![**Correlation analysis among lymphocyte number, function and phenotype.** (**A**) Correlation between lymphocyte function (including CD4^+^ T cells, CD8^+^ T cells, and NK cells) and lymphocyte number. (**B**) Correlation between lymphocyte phenotype (including the expression of CD28, HLA-DR, and CD45RO on CD4^+^ T cells or CD8^+^ T cells) and lymphocyte number. (**C**) Correlation among different lymphocyte phenotype markers (CD28, HLA-DR, and CD45RO), or correlation between lymphocyte function (including CD4^+^ and CD8^+^ T cells) and lymphocyte phenotype. Each symbol represents an individual donor.](aging-12-103208-g003){#f3}

Establishment of immune scoring model based on combination of the number, function and phenotype of lymphocytes
---------------------------------------------------------------------------------------------------------------

To quantitatively evaluate host immunity, an immune scoring model based on combination of lymphocyte number, function and phenotype was established as described in method section. Twenty and twenty-one samples of peripheral blood were collected from hyperimmune and hypoimmune patients, respectively. The demographic and clinical characteristics of these patients are shown in [Supplementary Table 3](#SD2){ref-type="supplementary-material"}. To match the patients with respect to age and sex, a total of 118 healthy individuals aged 23--76 years were selected. Half of them were finally selected by using the random under-sampling method. The mean score of the immune scoring model in these 59 healthy individuals is 0. In hyperimmune group, the score of the model ranged from -1 to 7, and the mean score was 2.15 (score \< 0, n = 3; score = 0, n = 3; score \> 0, n = 14). In hypoimmune group, the score of the model ranged from -14 to 1, the mean score was -5.19 (score \< 0, n = 15; score = 0, n=5; score \> 0, n = 1). If using score \> 0 as cutoff value, the immune scoring model showed a sensitivity of 70% and a specificity of 100% in determining hyperimmune status. If using score \< 0 as cutoff value, the immune scoring model showed a sensitivity of 71.4% and a specificity of 100% in determining hypoimmune status. The score distribution of the participants in different immune status is shown in [Figure 4](#f4){ref-type="fig"}.

![**The score distribution of the immune scoring model (based on combination of lymphocyte number, function, and phenotype) in patients with hyperimmune and hypoimmune status.**](aging-12-103208-g004){#f4}

DISCUSSION
==========

The immune system plays a crucial role in maintaining health. However, how to quantitatively assess host immunity is still a challenge in clinical practice. Clinicians commonly use clinical information combined with a few laboratory tests such as peripheral white blood cell count and TBNK lymphocyte count to determine host immunity, which is obviously inaccurate as lymphocyte number cannot represent lymphocyte function. Based on our previously established PMA/ionomycin-stimulated lymphocyte function assay, we simultaneously assessed the number, function and phenotype of lymphocytes in this study. A further established immune scoring model based on combination of these indicators showed good performance in quantitatively determining host immunity.

In accordance with previous studies, our results demonstrated that the number of both T cells (including CD4^+^ and CD8^+^ T cells) and B cells gradually decreased with increasing age \[[@r12], [@r13]\]. Previous studies have also shown that the diversity of B cell phenotype is decreased in elderly people, which results in decreased protective effect of vaccination in them compared with young people \[[@r12], [@r14]--[@r16]\]. These data suggest that the number of adaptive immune cells gradually decreases during life. Furthermore, NK cells are one of the key components of the innate immune system. Contrastingly, however, the number of NK cells slowly increases with increasing age. This is different from previous studies showing that NK cell count maintains stable level in elderly individuals \[[@r11], [@r12]\]. One of the possible reasons is that participants in a continuous age range between 1 and 82 years were used to describe age-related change in this study, whereas previous studies only included a limited age group to determine the number of NK cells. Our data suggest that age-related changes between the number of adaptive and innate immune cells are different.

Rare studies have determined the relationship between lymphocyte function and age. The most probable cause is that current methods, such as CFSE proliferation assay and CD107a degranulation assay, are complicated and time-consuming and not suitable for clinical application \[[@r5], [@r17]--[@r19]\]. Based on our previously established PMA/ionomycin-stimulated lymphocyte function assay, we found a robust positive correlation between T cell function and age \[[@r11]\]. We proposed that the increase of function in CD4^+^ and CD8^+^ T cells with increasing age is to maintain certain degree of immune function, as the numbers of CD4^+^ and CD8^+^ T cells have been declining during life. Interestingly, the function of NK cells was maintained at a high level after birth and slowly increased with increasing age. These data suggest that innate immunity is more important for children and elders, because the function of adaptive immune cells is immature in children and the number of them is insufficient in elders. These data are consistent with previous findings indicating that NK cells play an important role in the immunity of elders and may be interpreted as a factor of longevity \[[@r20]--[@r23]\].

Many surface molecules are selectively expressed on different lymphocyte subsets and are described as lymphocyte phenotype. We chose several classical phenotype markers of lymphocytes including CD28 (naive marker), CD45RA (naive marker), HLA-DR (activated marker) and CD45RO (memory marker) to reflect host immunity. These phenotype markers are correlated with lymphocyte function and are known to play an important role in many diseases such as infection, tumor, and autoimmune disease \[[@r24]--[@r27]\]. As expected, our data demonstrated that the expression of CD28 on T cells gradually decreased with increasing age and was negatively correlated with their function. An opposite phenomenon was observed in the expressions of HLA-DR and CD45RO on T cells. These data suggest that the potential of immunity in elders is reduced and that a high expression of CD28 can be used to predict longevity, which is in accordance with previous studies \[[@r28], [@r29]\]. Since CD45RA and CD45RO are different CD45 isoforms expressed on T cells, we did not analyze the results of CD45RA in case of repetition.

Both the number and function of lymphocytes are critical to maintain normal immunity. Either the decreased lymphocyte number or the impaired lymphocyte function can lead to immunodeficiency. Thus, the assessment of immunity depends on the combination of lymphocyte number and function. Nevertheless, rare studies have established immune scoring model to assess immunity based on combination of these two aspects. Since different lymphocyte phenotypes are also correlated with different lymphocyte function, we first established an immune scoring model based on combination of the number, function and phenotype of lymphocytes to comprehensively assess host immunity. The imbalance of immunity leads to many immune-related diseases, such as autoimmune disease (hyperimmune status) \[[@r30]\] and opportunistic infection (hypoimmune status) \[[@r31]--[@r36]\]. The validation data from patients with different immune status showed that the model had high sensitivities in the determination of both hyperimmune and hypoimmune status. An immune scoring model based on combination of lymphocyte number and function was also established. The model had a lower sensitivity than above model ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"})

Our study proposes a quantitative model for the evaluation of host immunity by combining the number, function and phenotype of lymphocytes. Previous studies have also incorporated relevant factors of immune system for differential diagnosis of diseases \[[@r37]--[@r39]\]. Castelblanco et al used a model by combination of adiponectin, soluble tumor necrosis factor-α receptor 2, interleukin-6, hs-CRP and leukocyte number to differentiate among different types of diabetes \[[@r37]\]. Qiu et al used neutrophil--lymphocyte ratio (NLR) to evaluate triple-negative breast cancer. Patients with NLR lower than 2.85 exhibited significantly higher overall survival and disease-free survival than those with higher NLR \[[@r38]\]. Qiu et al compared the differences in lymphocyte subsets between cancer patients and healthy people \[[@r39]\]. Although many studies compared the number and phenotype of lymphocytes in patients with different diseases, rare studies further established a model.

The immune scoring model established in the present study can assist in the diagnosis and prognosis of various diseases. We speculated that the model can be also used to monitor the effect of treatment in immune-related diseases. For example, the model can be used to comprehensively evaluate the host's immune status and determine the optimal dosage of immunosuppressant in patients after transplantation. This model can also assist clinicians to determine the causes of disease and choose the right treatment in patients with infectious diseases.

Taken together, we put forward that an immune scoring model based on combination of lymphocyte number, function and phenotype has potential value in the assessment of host immunity.

MATERIALS AND METHODS
=====================

Subjects
--------

This study was carried out from May 2018 to June 2019 at Tongji Hospital (the largest hospital in central China). A total of 261 healthy individuals (168 males, 93 females) aged 1-82 years were recruited. These subjects were determined by clinical interview and physical examination to be free of illness. Exclusion criteria were as follows: pregnancy, atherosclerosis and vascular disease, cardiopathy, chronic nephropathy, hepatobiliary disease, allergic disease, autoimmune disease, hematological disease, myopathy, burns and muscle trauma, positive for HIV, HBV, HCV, CMV, and syphilis antibodies. Another two groups of patients with hyper-immune and hypo-immune status were also recruited. Patients with autoimmune diseases were defined according to the criteria of the American College of Rheumatology and were classified as hyperimmune group. Patients infected with opportunistic pathogens including aspergillus, pneumocystis carinii and cryptococcus neoformans were classified as hypoimmune group. This study was approved by the ethical committee of Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China.

Lymphocyte count
----------------

Heparinized peripheral blood was collected from study participants. The percentages and absolute numbers of CD4^+^ T cells, CD8^+^ T cells, B cells and NK cells were determined by using TruCOUNT tubes and BD Multitest 6-color TBNK Reagent Kit (BD Biosciences) according to the manufacturer\'s instructions. In brief, 50 μl of whole blood was labeled with 6-color TBNK antibody cocktail for 15 min in room temperature. After adding 450 μl of FACS Lysing Solution, samples were analyzed with FACSCanto flow cytometer using FACSCanto clinical software (BD Biosciences). Cells with CD45 high expression and with low side scatter were gated as lymphocytes. TruCOUNT beads were gated based on side scatter and fluorescence intensity. CD3^+^ cells in lymphocyte gate were defined as total T cells. CD4^+^CD8^-^ and CD8^+^CD4^-^ cells in CD3^+^ cells were defined as CD4^+^ T cells and CD8^+^ T cells, respectively. CD19^+^ and CD16^+^CD56^+^ cells in CD3^-^ cells were defined as B cells and NK cells, respectively.

Lymphocyte function analysis
----------------------------

Heparinized peripheral blood was collected from study participants. PMA/ionomycin-stimulated lymphocyte function assay was performed as described previously \[[@r11]\]. The procedures are described in brief as follows: 1) 100 μl of whole blood was diluted with 400 μl of IMDM medium; 2) the diluted whole blood was incubated in the presence of Leukocyte Activation Cocktail (Becton Dickinson GolgiPlug) for 4 h; 3) the cells were labeled with monoclonal antibodies (anti-CD45, anti-CD3, anti-CD4, anti-CD56, and anti-CD8); 4) the cell were fixed and permeabilized; 5) the cells were stained with intracellular anti-IFN-γ antibody; and 6) the cells were analyzed with FACSCanto flow cytometer. The percentages of IFN-γ^+^ cells in different cell subsets were defined as the function of them (e.g., the percentage of IFN-γ^+^ cells in CD3^+^CD4^+^CD8^-^ cells was defined as the function of CD4^+^ T cells; the percentage of IFN-γ^+^ cells in CD3^+^CD8^+^CD4^-^ cells was defined as the function of CD8^+^ T cells; the percentage of IFN-γ^+^ cells in CD3^-^CD56^+^ cells was defined as the function of NK cells).

Lymphocyte phenotype analysis
-----------------------------

Heparinized peripheral blood was collected from study participants. The following monoclonal antibodies were added to 100 μl of whole blood: anti-CD45, anti-CD3, anti-CD4, anti-CD8, anti-CD28, anti-HLA-DR, anti-CD45RA, and anti-CD45RO (BD Biosciences). Isotype controls with irrelevant specificities were included as negative controls. All of these cell suspensions were incubated for 20 min at room temperature. After lysing red blood cells, the cells were washed and resuspended in 200 μl of PBS. The cells were then analyzed with FACSCanto flow cytometer.

Establishment of immune scoring model
-------------------------------------

The following 8 parameters were used for establishing immune scoring model: CD4^+^ T cell number × function, CD28^+^CD4^+^ T cell number, HLA-DR^+^CD4^+^ T cell number, CD45RO^+^CD4^+^ T cell number, CD8^+^ T cell number × function, CD28^+^CD8^+^ T cell number, HLA-DR^+^CD8^+^ T cell number, and NK cell number × function. The reference range of each parameter was established in healthy individuals according to the above-described methods. The immune scoring model which is similar with Sequential Organ Failure Assessment scoring in sepsis was established \[[@r40], [@r41]\], as the following rules: 1) if the values of these parameters were higher than 1.5 times the upper limit of the normal reference range, score of + 2 was recorded; 2) if the values of these parameters were between 1 and 1.5 times the upper limit of the normal reference range, score of + 1 was recorded; 3) if the values of these parameters were within the normal reference range, score of 0 was recorded; 4) if the values of these parameters were between 0.5 and 1 times the lower limit of the normal reference range, score of -1 was recorded; and 5) if the values of these parameters were lower than 0.5 times the lower limit of the normal reference range, score of -2 was recorded. The scores of these 8 parameters for each individual were summarized to calculate the total score.

Statistical analysis
--------------------

Statistical significance between different groups of participants was analyzed using the Mann--Whitney *U*-test. Spearman\'s rank correlation test for non-parametric data was employed to analyze the relationship between two factors. The reference ranges of parameters were determined by using the 2.5--97.5 percentile nonparametric range. The statistical analysis was performed using GraphPad Prism version 6 (GraphPad Software, San Diego, CA, USA). Statistical significance was determined as *p* \< 0.05 (\**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001).
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